Hire Dr. Vitthal Kulkarni, a pharma consultant specializing in Anlaytical Testing, Clinical Studies and Pharmaceutical Quality. See services offered, experience summary, and connect via apicule.
Based in: U.S.A.
Willing to work in: Global
Consultant Type: Independent Consultant
Expertise summary: Dr. Vitthal S. Kulkarni is an independent pharmaceutical consultant with 20+ years of experience in complex non-sterile drug product development, with particular expertise in semi-solids, liquids, and nasal spray dosage forms. His background combines formulation development, product characterization, regulatory strategy, CMC alignment, and lifecycle support across generic and innovative products. He helps pharmaceutical teams move products from concept to manufacturing readiness through science-driven development, practical implementation, and strong regulatory alignment.
Dr. Kulkarni supports analytical development for complex non-sterile drug products with a strong focus on scientifically sound characterization and development strategy. His work includes deep product and excipient understanding, advanced physico-chemical evaluation, and support for formulation and characterization activities required for semi-solids, liquids, and nasal sprays. He helps teams generate meaningful analytical insight that supports formulation decisions, product understanding, and smoother development progression toward manufacturable and regulatory-aligned products.
Dr. Kulkarni supports CMC-related development through an integrated understanding of formulation, characterization, manufacturability, regulatory expectations, and lifecycle strategy. His website highlights experience in developing complex generic and innovative products from concept to manufacturing, with strong alignment to CMC requirements and product-specific guidance for ANDA submissions. He helps pharmaceutical teams strengthen CMC thinking early by connecting formulation decisions, excipient/API selection, manufacturing readiness, and regulatory expectations into a more coherent development path.
Dr. Kulkarni supports method validation through study design guidance and product-specific scientific evaluation aligned with regulatory expectations. His consulting approach includes support for validation strategy, test method review, and broader characterization work needed for complex dosage forms such as semi-solids, liquids, and nasal sprays. He helps organizations strengthen validation planning and technical justification so analytical methods are more appropriate, defensible, and development-stage relevant.
Dr. Kulkarni supports quality assurance through a development-focused approach that combines scientific rigor, regulatory alignment, and practical implementation for complex non-sterile drug products. His work includes critical review of scientific data, reports, protocols, SOPs, test methods, specifications, and broader development documentation required to support semi-solids, liquids, and nasal spray programs. He helps teams strengthen product understanding, documentation quality, and development-stage compliance so that formulation, characterization, and manufacturing readiness are built on a more reliable and regulatory-aligned foundation.
Dr. Kulkarni supports regulatory filing through scientific and strategic guidance tied closely to CMC expectations, product-specific guidance, and documentation quality. His consulting work includes regulatory affairs support, document review, submission-related requirements, and support for development programs aligned with ANDA, NDA, IND, and OTC pathways. He helps organizations strengthen the scientific quality and regulatory relevance of supporting data, documents, and development strategy for complex non-sterile products.
Dr. Kulkarni supports stability studies as part of broader drug product development and characterization programs for complex non-sterile dosage forms. His website specifically highlights guidance on stability studies in conjunction with compatibility assessments, comparability to RLD, and formulation development for semi-solids, liquids, and nasal sprays. He helps teams design stability-focused development strategies that better support product understanding, formulation robustness, and regulatory readiness.
